Spherical and tubule nanocarriers for sustained drug release

Curr Opin Pharmacol. 2014 Oct:18:141-8. doi: 10.1016/j.coph.2014.10.001. Epub 2014 Oct 18.

Abstract

We discuss new trends in Layer-by-Layer (LbL) encapsulation of spherical and tubular cores of 50-150 nm diameter and loaded with drugs. This core size decrease (from few micrometers to a hundred of nanometers) for LbL encapsulation required development of sonication assistant non-washing technique and shell PEGylation to reach high colloidal stability of drug nanocarriers at 2-3mg/mL concentration in isotonic buffers and serum. For 120-170 nm spherical LbL nanocapsules of low soluble anticancer drugs, polyelectrolyte shell thickness controls drug dissolution. As for nanotube carriers, we concentrated on natural halloysite clay nanotubes as cores for LbL encapsulation that allows high drug loading and sustains its release over tens and hundreds hours. Further drug release prolongation was reached with formation of the tube-end stoppers.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Aluminum Silicates / administration & dosage
  • Aluminum Silicates / chemistry
  • Animals
  • Clay
  • Delayed-Action Preparations / administration & dosage
  • Delayed-Action Preparations / chemistry
  • Drug Carriers* / administration & dosage
  • Drug Carriers* / chemistry
  • Humans
  • Nanostructures* / administration & dosage
  • Nanostructures* / chemistry

Substances

  • Aluminum Silicates
  • Delayed-Action Preparations
  • Drug Carriers
  • Clay